CGX Systems

Cognionics operates in a specialized segment spanning neurotechnology, research instrumentation, medical devices, and wearable hardware. Its differentiation is centered on research-grade EEG acquisition without conductive gels, combining dry electrodes, headset mechanics, electronics, and software-compatible data output in one system. The company’s technology references include Drypad flat sensors for bare skin, Flex sensors designed to work through hair, 24-bit acquisition, greater than 100 dB common-mode rejection, Bluetooth Low Energy telemetry, and patented real-time impedance monitoring. This focus places Cognionics near wireless EEG and neuro-sensing alternatives such as NeuroSky and Compumedics, both named in market coverage alongside the company. Cognionics appears more oriented toward professional research and configurable raw-data collection than mass-market consumer neurotechnology: it supports EEG, EDF, BDF, and CSV outputs and emphasizes unfiltered signals. The available profile does not establish market share, regulatory approvals, recurring revenue, or comparative commercial scale, so its competitive position should be viewed as technology-led and niche rather than broadly validated. Its San Diego base, eight granted patents, and integration of hardware and sensing technologies provide meaningful technical differentiation, while limited disclosure on customers and financing constrains assessment of market penetration.

Cognionics’ trajectory appears to have developed from a research-driven hardware foundation into a focused platform for mobile and dry-electrode EEG. Founded in 2010, the company identifies Gert Cauwenberghs as founder, with his recorded role beginning in 2011. Its current offering combines dry sensors, headset mechanics, active shielding, pre-amplification, wireless telemetry, impedance monitoring, and multimodal physiological monitoring rather than relying on a single electrode component. The product architecture suggests an effort to reduce preparation time and make research-grade EEG practical in less controlled environments. The company’s technology development has also been associated with research connected to DARPA, NASA, NIH, the Office of Naval Research, the Air Force Research Laboratory, and the Army Research Laboratory, indicating a history of technically demanding application areas. Eight granted patents provide evidence of accumulated intellectual property. The employee band is estimated at 11–50, with only one current position explicitly identified. Accordingly, the evidence supports sustained technical development and product continuity, but does not demonstrate a recent acceleration in commercial scale.